Joel Isaacson & Co. LLC Buys 662 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Joel Isaacson & Co. LLC boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 11.4% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 6,468 shares of the healthcare conglomerate’s stock after buying an additional 662 shares during the quarter. Joel Isaacson & Co. LLC’s holdings in UnitedHealth Group were worth $3,272,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently bought and sold shares of UNH. Kathleen S. Wright Associates Inc. bought a new position in UnitedHealth Group in the 3rd quarter worth $27,000. AlphaMark Advisors LLC bought a new stake in UnitedHealth Group during the 4th quarter valued at approximately $30,000. RPg Family Wealth Advisory LLC purchased a new position in shares of UnitedHealth Group in the 3rd quarter valued at approximately $37,000. Friedenthal Financial bought a new position in UnitedHealth Group in the third quarter worth $51,000. Finally, Highline Wealth Partners LLC bought a new stake in shares of UnitedHealth Group during the 3rd quarter valued at $55,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insiders Place Their Bets

In related news, Director Timothy Patrick Flynn bought 1,000 shares of the stock in a transaction dated Friday, January 17th. The shares were purchased at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.33% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

Several research firms recently commented on UNH. TD Cowen boosted their price objective on shares of UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. Piper Sandler reduced their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research report on Thursday, January 2nd. Morgan Stanley reduced their price target on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a report on Wednesday, October 16th. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Finally, Wells Fargo & Company reduced their price target on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research report on Tuesday, January 28th. One research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Buy” and a consensus target price of $629.32.

UnitedHealth Group Trading Down 0.6 %

Shares of UNH stock opened at $526.68 on Friday. The company has a market cap of $484.69 billion, a price-to-earnings ratio of 33.98, a PEG ratio of 1.45 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The firm has a fifty day moving average price of $530.85 and a 200-day moving average price of $564.52. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The company had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm’s revenue was up 6.8% on a year-over-year basis. During the same period in the previous year, the company posted $5.83 EPS. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.